집 » 모두 » 주식 예측 » Supernus Pharmaceuticals Inc. Common Stock 예측

Supernus Pharmaceuticals Inc. Common Stock 예측: 내일, 주, 월, 5년

업데이트됨: April 22 · 2026 at 07:03 UTC

From

▼ -4.16%Market Cap $2.82B · Technical analysis Bearish · Focus area Price + volatility

예측 요약

기간	예상 가격	과거	역사적인	통찰력
내일	$49.81 ▲ +1.41%	어제	$48.83 ▼ -0.59%	Tomorrow's Supernus Pharmaceuticals Inc. Common Stock (SUPN) setup is anchored to $49.12 and targets $49.81 (+1.41%). The near-term read is upside; watch $50.59 / $47.65 because daily realized volatility is about 7.29%.
Tomorrow's Supernus Pharmaceuticals Inc. Common Stock (SUPN) setup is anchored to $49.12 and targets $49.81 (+1.41%). The near-term read is upside; watch $50.59 / $47.65 because daily realized volatility is about 7.29%.
주	$51.28 ▲ +4.40%	지난주	$48.21 ▼ -1.85%	The 7-day Supernus Pharmaceuticals Inc. Common Stock model moves from $48.21 to $51.28 (+4.40%). It gives upside momentum context for this stock, so breaks around $50.59 / $47.65 matter more than a single tick.
The 7-day Supernus Pharmaceuticals Inc. Common Stock model moves from $48.21 to $51.28 (+4.40%). It gives upside momentum context for this stock, so breaks around $50.59 / $47.65 matter more than a single tick.
월	$53.72 ▲ +9.37%	전달	$47.19 ▼ -3.94%	The 1-month Supernus Pharmaceuticals Inc. Common Stock target is $53.72 (+9.37%), compared with the live reference near $49.12. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month Supernus Pharmaceuticals Inc. Common Stock target is $53.72 (+9.37%), compared with the live reference near $49.12. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
년도	$57.38 ▲ +16.82%	작년	$45.65 ▼ -7.07%	The 1-year Supernus Pharmaceuticals Inc. Common Stock scenario points to $57.38 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year Supernus Pharmaceuticals Inc. Common Stock scenario points to $57.38 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5년	$65.96 ▲ +34.29%	5년 전	$42.05 ▼ -14.40%	The 5-year Supernus Pharmaceuticals Inc. Common Stock view is $65.96 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year Supernus Pharmaceuticals Inc. Common Stock view is $65.96 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

내일$49.81▲ +1.41%

어제$48.83▼ -0.59%

Tomorrow's Supernus Pharmaceuticals Inc. Common Stock (SUPN) setup is anchored to $49.12 and targets $49.81 (+1.41%). The near-term read is upside; watch $50.59 / $47.65 because daily realized volatility is about 7.29%.

주$51.28▲ +4.40%

지난주$48.21▼ -1.85%

The 7-day Supernus Pharmaceuticals Inc. Common Stock model moves from $48.21 to $51.28 (+4.40%). It gives upside momentum context for this stock, so breaks around $50.59 / $47.65 matter more than a single tick.

월$53.72▲ +9.37%

전달$47.19▼ -3.94%

The 1-month Supernus Pharmaceuticals Inc. Common Stock target is $53.72 (+9.37%), compared with the live reference near $49.12. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

년도$57.38▲ +16.82%

작년$45.65▼ -7.07%

The 1-year Supernus Pharmaceuticals Inc. Common Stock scenario points to $57.38 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5년$65.96▲ +34.29%

5년 전$42.05▼ -14.40%

The 5-year Supernus Pharmaceuticals Inc. Common Stock view is $65.96 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

가격 차트

역사적인예측강세약세

기술적 분석

Neutral

강세

중립적

약세

주요 지표

지시자	값	신호
Price	$49.12	Mid
Daily Change	-4.16%	Below
Volatility Cap	20.0%	Mid
Confidence	66%	Above
Data Source	nasdaq-screener	Mid

과거 데이터

Current$49.12

Daily Change-4.16%

Market Cap$2.82B

Sourcenasdaq-screener

Current	$49.12	Daily Change	-4.16%
Market Cap	$2.82B	Source	nasdaq-screener

지지 및 저항 수준

$47.65Support 1

$49.12현재의

$50.59Resistance 1

shield

Support and resistance are estimated from the trusted current price until deeper historical data is available.

가격 이정표

주요 수준 및 역사적 맥락

Current$49.12Live reference price

Used as the anchor for generated forecast calculations.

Next Month$53.72Model projection+9.37%

Directional scenario based on capped drift.

예측 정확도

우리 모델의 성능

66%

방향성

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

우리의 알고리즘은 최신 가격 조치, 변동성 체제 및 지표 신호를 사용하여 매주 재보정됩니다. 정확도는 기간에 따라 다릅니다. 단기적인 모멘텀이 장기 예측보다 더 안정적입니다.

Short term

66%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

투자 시나리오

오늘 SUPN에 $1,000를 투자한다면

Bullish Scenario

$51.58

+5.00% from current

목표가격$51.58

대본Upside momentum

개연성58%

Base Scenario

$53.72

+9.37%

목표가격$53.72

대본Capped drift

개연성66%

Bearish Scenario

$46.66

-5.00% from current

목표가격$46.66

대본Volatility drawdown

개연성34%

기초: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

예측 요인

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 70/100

24H drift+1.41%

7D drift+4.40%

30D drift+9.37%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 67/100

1M outlook+9.37%

1Y outlook+16.82%

5Y outlook+34.29%

자주 묻는 질문

Q What is the Supernus Pharmaceuticals Inc. Common Stock (SUPN) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), Supernus Pharmaceuticals Inc. Common Stock is projected near $49.81 versus the current reference around $49.12. That implies a modeled move of +1.41% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for SUPN?

The weekly Supernus Pharmaceuticals Inc. Common Stock model points to $51.28, which maps to an expected drift of +4.40% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the Supernus Pharmaceuticals Inc. Common Stock 1-month and 1-year targets?

The Supernus Pharmaceuticals Inc. Common Stock 1-month target is $53.72 (+9.37%), while the 1-year target is $57.38 (+16.82%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the Supernus Pharmaceuticals Inc. Common Stock 5-year scenario differ from short-term rows?

The Supernus Pharmaceuticals Inc. Common Stock long-horizon scenario sits near $65.96 with a modeled change of +34.29%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are SUPN support and resistance zones right now?

For Supernus Pharmaceuticals Inc. Common Stock, nearest resistance is around $47.65, while nearest support is around $50.59. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the Supernus Pharmaceuticals Inc. Common Stock market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.